1. Home
  2. BOXL vs PPCB Comparison

BOXL vs PPCB Comparison

Compare BOXL & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boxlight Corporation

BOXL

Boxlight Corporation

N/A

Current Price

$4.43

Market Cap

3.1M

ML Signal

N/A

Logo Propanc Biopharma Inc.

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.50

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BOXL
PPCB
Founded
1985
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.6M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
BOXL
PPCB
Price
$4.43
$0.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.2K
★ 193.9K
Earning Date
11-05-2026
09-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $25,743,612.00
N/A
Revenue This Year
$0.69
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 26.37
N/A
52 Week Low
$0.50
$0.06
52 Week High
$9.89
$6.79

Technical Indicators

Market Signals
Indicator
BOXL
PPCB
Relative Strength Index (RSI) N/A 32.38
Support Level N/A $0.10
Resistance Level N/A $1.29
Average True Range (ATR) 0.00 0.08
MACD 0.00 -0.01
Stochastic Oscillator 0.00 4.90

Price Performance

Historical Comparison
BOXL
PPCB

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: